Caspian Therapeutics, Inc.

New Filing
CIK: 0002156247·Biotechnology·DELAWARE·Filed: Sep 23, 2026
Total Offering

$50,000,000

Amount Sold

$50,000,000

Investors

43

First Sale

Sep 8, 2026

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2026
Non-Accredited Investors
No

Related Persons

NameRole
Robert H. Spencer
Troy E. Wilson
Spike Loy

Company

Caspian Therapeutics, Inc.

4930 DIRECTORS PLACE

SAN DIEGO, CA, 92121

(858) 500-8800

SEC Filing

0001231919-26-001219

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free